https://biotechmorning.com/news/trump-rescission-billion-biotech-pipeline Biotech Morning en 2026-09-27T14:18:05.603Z The $1 Billion Disappearing Act That Could Starve Biotech's Pipeline https://biotechmorning.com/news/in-vivo-car-t-iaso-bio-first-human-data Biotech Morning en 2026-09-27T14:17:25.796Z What If Your Body Could Build Its Own Cancer Therapy? https://biotechmorning.com/news/lilly-innocare-3-billion-china-licensing-deal Biotech Morning en 2026-09-27T14:16:34.525Z Lilly Just Bet $3.35 Billion on a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-deaths Biotech Morning en 2026-09-27T14:15:37.077Z Sarepta's Gene Therapy Was Supposed to Change Everything. Then Kids Started Dying. https://biotechmorning.com/news/lundbeck-ditches-midwest-for-boston Biotech Morning en 2026-09-27T14:14:48.677Z Why Lundbeck Just Ditched the Midwest for Boston's Brain Belt https://biotechmorning.com/news/roche-magl-inhibitor-progressive-ms Biotech Morning en 2026-09-27T14:14:03.685Z Roche's Unusual Bet on a Lipid Enzyme Could Crack Progressive MS Wide Open https://biotechmorning.com/news/lilly-breast-cancer-combo-approval Biotech Morning en 2026-09-27T14:13:19.176Z Lilly's Secret Weapon in Breast Cancer Isn't What You Think https://biotechmorning.com/news/revolution-medicines-ras-pancreatic-cancer-drug Biotech Morning en 2026-09-27T14:12:32.459Z The Cancer Gene Nobody Could Drug (Until Now) https://biotechmorning.com/news/novo-nordisk-orbis-macrocycle-oral-deal Biotech Morning en 2026-09-27T14:11:45.970Z Novo Nordisk Really Wants You to Swallow a $1.4B Pill https://biotechmorning.com/news/lilly-2-9-billion-merida-biosciences-acquisition-2 Biotech Morning en 2026-09-27T14:11:00.379Z Lilly Just Dropped $2.9 Billion on a Company You've Never Heard Of https://biotechmorning.com/news/nutshell-therapeutics-nts231-triple-mechanism-degrader Biotech Morning en 2026-09-26T14:17:54.686Z The Drug That Breaks Three Rules at Once Just Got Its Shot https://biotechmorning.com/news/eli-lilly-90m-nektar-unwritten-rule Biotech Morning en 2026-09-26T14:17:07.638Z Eli Lilly Just Lost $90M for Breaking an Unwritten Rule https://biotechmorning.com/news/child-died-china-gene-editing-trial-transparency Biotech Morning en 2026-09-26T14:16:21.615Z A Child Died in a Chinese Gene-Editing Trial. The World Found Out a Year Later. https://biotechmorning.com/news/fop-zilurgisertib-fda-approval-mirum Biotech Morning en 2026-09-26T14:15:36.012Z The Disease That Turns You Into a Statue Just Got Its Newest Enemy https://biotechmorning.com/news/merck-daiichi-sankyo-second-fda-withdrawal Biotech Morning en 2026-09-26T14:14:54.377Z Merck and Daiichi Sankyo's $22 Billion Bet Just Hit Its Second Speed Bump https://biotechmorning.com/news/abbvie-iambic-ai-drug-discovery-deal Biotech Morning en 2026-09-26T14:14:08.523Z AbbVie Just Bet Big on a Robot Chemist Backed by Nvidia https://biotechmorning.com/news/china-newco-consultant-double-dealing-lawsuit Biotech Morning en 2026-09-26T14:13:25.245Z The Consultant Who Played Both Sides of China's Hottest Biotech Deal Machine https://biotechmorning.com/news/boehringer-billion-dollar-rna-splicing-envisagenics Biotech Morning en 2026-09-26T14:12:36.035Z Boehringer's Billion-Dollar Bet on Biology's Best-Kept Secret https://biotechmorning.com/news/novo-nordisk-nanexa-pharmashell-deal Biotech Morning en 2026-09-26T14:11:45.844Z Novo Nordisk Just Paid $1.3B for a Coating Thinner Than a Soap Bubble https://biotechmorning.com/news/parkinsons-first-new-dopamine-drug-type-decades Biotech Morning en 2026-09-26T14:10:59.502Z Parkinson's Gets Its First New Type of Dopamine Drug in Decades https://biotechmorning.com/news/gene-therapy-sanfilippo-syndrome-fda-approval Biotech Morning en 2026-09-26T14:10:14.400Z The $3.9 Million Shot That Could Save Kids With No Other Options